Immunic, Inc.
Immunic, Inc.（IMUX）股东结构
基于 13F 申报与流通股数据，展示机构、内部人与公众持股结构；下方为前十大机构、机构动向与内部人交易。
SEC 13F · FMP · IMUX · 截至 2025年9月30日
股东结构概览
65
机构持有人数
▲ 7 vs Q2
$37.64M
机构持仓总市值
▲ $2.63M vs Q2
9.87M
总流通股
freeFloat 96.88%
42.69M
13F 申报持股数
▼ 7.49M vs Q2
机构持仓% = 13F 持股数 ÷ 总流通股。内部人% = 100 − 自由流通率。散户% = 自由流通率 − 机构%。数据来源：FMP /symbol-positions-summary + /shares-float + SEC EDGAR。
前10大机构持仓
IMUX 最大股东 · 机构持仓
Q3 2025 · SEC 13F
显示前 10 家
| 机构 | 持股数 | 占比 | 权重 | 市值 | 申报日 | 变动 |
|---|---|---|---|---|---|---|
ABRDN PLC pharmaceutical preparations | 8.24M | 6.24% | 6.24% | $7.27B | Nov 7, 2025 | — held |
BVF INC/IL pharmaceutical preparations | 7.65M | 5.79% | 5.79% | $6.75B | Nov 14, 2025 | — held |
AVIDITY PARTNERS MANAGEMENT LP pharmaceutical preparations | 4.70M | 3.56% | 3.56% | $4.14B | Nov 14, 2025 | ▼ 916.4K |
VANGUARD GROUP INC pharmaceutical preparations | 4.35M | 3.29% | 3.29% | $3.83B | Nov 7, 2025 | ▲ 220.0K |
MORGAN STANLEY pharmaceutical preparations | 3.10M | 2.35% | 2.35% | $2.74B | May 27, 2026 | ▼ 525.4K |
COLONY GROUP, LLC pharmaceutical preparations | 2.58M | 1.95% | 1.95% | $2.28B | Nov 14, 2025 | ▲ 39.1K |
LAURION CAPITAL MANAGEMENT LP pharmaceutical preparations | 1.88M | 1.42% | 1.42% | $1.66B | Nov 17, 2025 | ▼ 22.9K |
SOLEUS CAPITAL MANAGEMENT, L.P. pharmaceutical preparations | 1.58M | 1.20% | 1.20% | $1.39B | Nov 14, 2025 | ▼ 5.71M |
ADAGE CAPITAL PARTNERS GP, L.L.C. pharmaceutical preparations | 1.40M | 1.06% | 1.06% | $1.23B | Nov 14, 2025 | — held |
GEODE CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 1.03M | 78.21% | 78.21% | $911.65M | Nov 12, 2025 | ▲ 59.1K |
数据来源：SEC 13F 申报文件。变动标识：isNew / isSoldOut / changeInSharesNumber。
机构仓位变动
Q3 2025 对比上季度
Q3 2025
15
增持
+2.13M 股9
新建仓
首次建仓6
减持
−7.56M 股0
清仓
完全退出净股数变化（前50家）
5.43M
+2.13M / −7.56M
净新增持仓人
+18
新建 9 个 / 退出 0 个
基于前50家最大机构持仓统计，全市场实际数量可能不同。
内幕交易买卖情绪
IMUX 内幕交易记录
数据来源：SEC Form 4
2
买入笔数
0
卖出笔数
0.00
买卖比
$0M
卖出总金额
最近内幕交易记录
最近10条 · 仅普通股
| 姓名 · 职位 | 日期 | 类型 | 股数 | 价格 | 金额 | 交易后持股 | 申报 |
|---|---|---|---|---|---|---|---|
Lundgren Erik Chief Executive Officer | May 22, 2026 | Award | 1,000,000 | $13.05 | $13.05M | 1.00M | Form 4 ↗ |
Panzara Michael A. Chief Medical Officer | Apr 24, 2026 | Award | 300,000 | $8.80 | $2.64M | 300.0K | Form 4 ↗ |
Whaley Glenn Chief Financial Officer | Jul 16, 2025 | Award | 560,000 | $0.77 | $431.2K | 560.0K | Form 4 ↗ |
Whaley Glenn Chief Financial Officer | Jul 16, 2025 | Award | 280,000 | $0.77 | $215.6K | 280.0K | Form 4 ↗ |
Nash Duane Executive Chairman | Jul 16, 2025 | Award | 630,000 | $0.77 | $485.1K | 630.0K | Form 4 ↗ |
Nash Duane Executive Chairman | Jul 16, 2025 | Award | 315,000 | $0.77 | $242.6K | 315.0K | Form 4 ↗ |
Vitt Daniel CEO and Director | Jul 16, 2025 | Award | 1,720,000 | $0.77 | $1.32M | 1.72M | Form 4 ↗ |
Vitt Daniel CEO and Director | Jul 16, 2025 | Award | 860,000 | $0.77 | $662.2K | 860.0K | Form 4 ↗ |
Muehler Andreas Chief Medical Officer | Jul 16, 2025 | Award | 660,000 | $0.77 | $508.2K | 660.0K | Form 4 ↗ |
Muehler Andreas Chief Medical Officer | Jul 16, 2025 | Award | 330,000 | $0.77 | $254.1K | 330.0K | Form 4 ↗ |
数据来源：SEC Form 4。买卖方向：acquisitionOrDisposition A=买入，D=卖出。已排除 RSU 归属（M-Exempt）。
关于机构与内部人持股结构
Immunic, Inc.（IMUX）主要由机构投资者持有，机构持股比例约为 100.0%。公司内部人员持股约 3.12%，散户及公众持股约占剩余的 0.00%。
Immunic, Inc. 最大机构股东为 ABRDN PLC，截至 September 30, 2025 持有约 8.24 million 股，占总流通股的 6.24%。
目前共有 65 家机构持有 IMUX 股票，合计持仓市值约 $37,637,800，数据来源为最新 SEC 13F 申报。
常见问题
IMUX ownershipImmunic, Inc.（IMUX）主要由机构投资者持有，机构持股约 100.0%。最大股东为 ABRDN PLC，持股比例 6.24%。内部人员持股约 3.12%。数据来源 SEC Form 13F，截至 September 30, 2025。